Administering an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers

References

• WHO. Hepatitis B [Internet]; 2019. [cited 2020 Jan 3]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b
   Google Scholar
• Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol. 2012;55(4):296–302.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Shirazi R, Ram D, Rakovsky A, et al. Characterization of hepatitis B and delta coinfection in Israel. BMC Infect Dis. 2018;18(1):97.
   PubMedGoogle Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555.
   PubMed Web of Science ®Google Scholar
• Bassal R, Markovich MP, Weil M, et al. Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study. Epidemiol Infect. 2017;145(14):2890–2895.
   PubMed Web of Science ®Google Scholar
• Hartal M, Yavnai N, Galor I, et al. Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy. Vaccine. 2015;33(38):4878–4885.
   PubMed Web of Science ®Google Scholar
• Jack AD, Hall AJ, Maine N, et al. What level of hepatitis B antibody is protective? J Infect Dis. 1999;179(2):489–492.
   PubMed Web of Science ®Google Scholar
• Lu C, Ni Y, Chiang B, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15–18 years after neonatal immunization. J Infect Dis. 2008;197(10):1419–1426.
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Mahmoodi M, Majdzadeh R, et al. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010;28(3):623–631.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Bruden D, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214(1):16–22.
   PubMed Web of Science ®Google Scholar
• Simons BC, Spradling PR, Bruden DJT, et al. A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen. J Infect Dis. 2016;214(2):273–280.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Poland GA. Vaccination policies for healthcare workers in Europe. Vaccine. 2014;32(38):4876–4880.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Poland GA. Immunization of healthcare providers: a critical step toward patient safety. Vaccine. 2014;32(38):4813.
   PubMed Web of Science ®Google Scholar
• FitzSimons D, François G, Hall A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine. 2005;23(32):4158–4166.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romanò L, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005;366(9494):1379–1384.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599.
   PubMed Web of Science ®Google Scholar
• Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67(1):1–31.
   PubMed Web of Science ®Google Scholar
• De Schryver A, Claesen B, Meheus A, et al. Hepatitis B vaccination policies for student healthcare workers in Europe. J Hosp Infect. 2014;86(2):147–150.
   PubMed Web of Science ®Google Scholar
• Komatsu H, Klenerman P, Thimme R. Discordance of hepatitis B vaccination policies for healthcare workers between the United States, the United Kingdom and Germany. Hepatol Res. [cited 2019 Dec 17]. DOI:10.1111/hepr.13470
   Google Scholar
• Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297.
   PubMed Web of Science ®Google Scholar
• Hadler SC, Doto IL, Maynard JE, et al. Occupational risk of hepatitis B infection in hospital workers. Infect Control. 1985;6(1):24–31.
   PubMedGoogle Scholar
• Schillie S, Murphy TV, Sawyer M, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013;62(RR-10):1–19.
   PubMed Web of Science ®Google Scholar
• Coppeta L, Pompei A, Balbi O, et al. Persistence of immunity for hepatitis B virus among heathcare workers and Italian medical students 20 years after vaccination. Int J Environ Res Public Health. 2019;16(9):E1515. DOI:10.3390/ijerph16091515
   PubMed Web of Science ®Google Scholar
• Chang Y-C, Wang J-H, Chen Y-S, et al. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study. BMC Public Health. 2014;14(1):991.
   PubMedGoogle Scholar
• McMahon BJ, Dentinger CM, Bruden D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22‐year follow‐up study and response to a booster dose. J Infect Dis. 2009;200(9):1390–1396.
   PubMed Web of Science ®Google Scholar
• Hustache S, Moyroud L, Goirand L, et al. Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage. Eur J Clin Microbiol Infect Dis. 2017;36(8):1483–1489.
   PubMed Web of Science ®Google Scholar
• Leidner AJ, Murthy N, Chesson HW, et al. Cost-effectiveness of adult vaccinations: a systematic review. Vaccine. 2019;37(2):226–234.
   PubMed Web of Science ®Google Scholar
• Carmody E. Time to re-evaluate the effect of the adolescent booster of hepatitis B vaccine. Int J Infect Dis. 2017;60:88–90.
   PubMed Web of Science ®Google Scholar
• Lim MK, Franceschi S, Vaccarella S, et al. Sexual activity and hepatitis B and C virus infection among young adults after introduction of a vaccination program in an area of high endemicity. J Epidemiol. 2009;19(5):213–218.
   PubMed Web of Science ®Google Scholar